14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The FTI Journal continues its look at opportunities for private equity in distressed M&A given the p...
Read More >
Like Count Dracula emerging from his lair and draining his victims, the COVID-19 virus manifested it...
Read More >
Seyfarth Synopsis: As the mercury rises, California employers must comply with regulatory requiremen...
Read More >
This Employment Law This Week® Monthly Rundown discusses the most important developments for employe...
Read More >
COVID-19 Resource - Banks, borrowers and their supporting professionals, like everyone else, are ha...
Read More >
Private equity fund sponsors can breathe a sigh of relief last week as the First Circuit Court of Ap...
Read More >